Article History
Accepted: 20 May 2020
First Online: 25 June 2020
Competing Interests
: M.H. is affiliated with Semma Therapeutics (Consultant and SAB member) and Encellin Inc. (SAB member, stock holder). M.H. also holds stocks from Viacyte Inc.. The other authors declare no competing interests.